Regenerative Therapies Market Size, Trends, Shares, Insights and Forecast - 2027

1. REGENERATIVE THERAPIES MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Regenerative Therapies Market - Overview Regenerative therapy is the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function. It replaces damaged tissue or stimulates the body's own repair mechanisms to heal tissues or organs, thereby regenerating damaged tissues and organs in the body. The global Regenerative Therapies Market is estimated to account for US$ 10,421.5 Mn in terms of value in 2019 and is expected to reach US$ 45,940.7 Mn by the end of 2027. Rapid growth of stem cell businesses is expected to propel growth of the global regenerative therapies market over the forecast period. For instance, according to the study, “The US Direct-to-Consumer Marketplace for Autologous Stem Cell Interventions”, published in the journal Perspectives in Biology and Medicine, in 2018, the number of new stem cell businesses with websites doubled on average every year between 2009 and 2014, in the U.S. Global Regenerative Therapies Market: Opportunities Increasing prevalence of neurological disorders is expected to offer lucrative growth opportunities for players in the market. For instance, according to the study, “Prevalence of Parkinson’s disease (PD) across North America”, published in July 2018 in the journal Nature, the number of people suffering from PD is expected to reach 930,000 in 2020 and 1,238,000 in 2030. Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/regenerative-therapies-market-3712 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Global Regenerative Therapies Market: Restraints Lack of financial-backing of smaller firms is expected to hinder growth of the global regenerative therapies market. A common trait in the regenerative therapies industry is the unavailability of proper financing options for smaller organizations. This is one of the main factors hampering R&D in the field of regenerative therapies. Quite observed in resource-poor settings, many promising targets have been abandoned half way during clinical trial phase due to lack of financing support stemming from insufficient data on proven efficacy. Furthermore, emergence and growth of start-ups researching on and producing regenerative therapies has been hampered by lack of lucrative co-marketing collaborations from medical devices companies (especially in orthopedics – the largest application segment in terms of revenue generation) and in-licensing and out-licensing deals. Key Takeaways: Allograft held dominant position in the global regenerative therapies market in 2019, accounting for 57.7% share in terms of value, followed by xenograft and alloplast, respectively. Allograft is a biological regenerative material which is transplanted from one person to other i.e. from a donor to receiver. Orthopedic segment held dominant position in the global regenerative therapies market in 2019, accounting for 37.2% share in terms of value, followed by soft tissue repair, and cardiovascular, respectively. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/3712 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Market Trends Major players in the market are focused on developing novel platforms biological therapeutic products to expand their product portfolio. For instance, in March 2020, Pluristem Therapeutics Inc., a regenerative medicine company, announced that it has dosed three patients in two different hospitals in Israel under a compassionate use program for the treatment of COVID-19. Major players in the market are also focused on expanding their capabilities. For instance, in March 2020, BioStem Life Sciences, a subsidiary of BioStem Technologies Inc. The translational pipeline from basic research to the delivery of innovative stem cell- based therapies is covered by a variety of European legal instruments, ranging from regulations on marketing authorization (Regulation (EC) no. 1394/2007) to Directives about clinical trials (Directive 2001/20/EC) and guidelines of good clinical practice (Directive 2001/83/EC, Directive 2009/120/EC). March 2020: BioStem Life Sciences received its ISBT 128 Registration from the International Council for Commonality in Blood Banking Automation Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/3712 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved